NEWS: #SolenoTherapeutics' #VykatXR has become the first FDA-approved treatment for #PraderWillisyndrome (PWS), a rare #geneticdisorder that causes excessive appetite and obesity.
pharmaphorum.com/news/fda-cle...
1
1
0
0